The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which included: a) Assessment of stroke/VTE risk; b) Assessment of bleeding risk; c) Assessment of renal function, creatinine clearance, FBC and LFTs; d) Any adverse events related to anticoagulation; e) Assessment of medicine adherence; f) Choice of anticoagulant

Subject(s): Atrial fibrillation

Date of publication: 31 July 2017

NICE identity code: NM147